A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Various systemic agents have been assessed for the treatment of alopecia areata (AA); however, there is a paucity of comparative studies. Objective: To assess and compare cyclosporine and betamethasone minipulse therapy as treatments for AA with regard to effectiveness and safety. Methods: Data were collected from 88 patients who received at least 3 months of oral cyclosporine (n=51) or betamethasone minipulse therapy (n=37) for AA. Patients with ≥50% of terminal hair regrowth in the alopecic area were considered responders. Results: The responder of the cyclosporine group was 54.9% and that of the betamethasone minipulse group was 37.8%. In the cyclosporine group, patients with mild AA were found to respond better to the treatment. Based on the patient self-assessments, 70.6% of patients in the cyclosporine group and 43.2% of patients in the betamethasone minipulse group rated their hair regrowth as excellent or good. Side effects were less frequent in the cyclosporine group. Conclusion: Oral cyclosporine appeared to be superior to betamethasone minipulse therapy in terms of treatment effectiveness and safety.
Abstract
Background: Various systemic agents have been assessed for the treatment of alopecia areata (AA); however, there is a paucity of comparative studies. Objective: To assess and compare cyclosporine and betamethasone minipulse therapy as treatments for AA with regard to effectiveness and safety. Methods: Data were collected from 88 patients who received at least 3 months of oral cyclosporine (n=51) or betamethasone minipulse therapy (n=37) for AA. Patients with ≥50% of terminal hair regrowth in the alopecic area were considered responders. Results: The responder of the cyclosporine group was 54.9% and that of the betamethasone minipulse group was 37.8%. In the cyclosporine group, patients with mild AA were found to respond better to the treatment. Based on the patient self-assessments, 70.6% of patients in the cyclosporine group and 43.2% of patients in the betamethasone minipulse group rated their hair regrowth as excellent or good. Side effects were less frequent in the cyclosporine group. Conclusion: Oral cyclosporine appeared to be superior to betamethasone minipulse therapy in terms of treatment effectiveness and safety.
참고문헌 (23)
- Amor KT., "The use of cyclosporine in dermatology: part I", J Am Acad Dermatol, 63, pp.925~946 (2010)
- Alkhalifah A., "Alopecia areata update: part II. Treatment", J Am Acad Dermatol, 62, pp.191~202 (2010)
- Chao-Chun Yang, "Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata:A Retrospective Study", Annals of Dermatology, 25(4), pp.471~474 (2013), 대한피부과학회
- Kar BR., "Placebo-controlled oral pulse prednisolone therapy in alopecia areata", J Am Acad Dermatol, 52, pp.287~290 (2005)
- Kurosawa M., "A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata", Dermatology, 212, pp.361~365 (2006)
- Lester RS., "The risks of systemic corticosteroid use", Dermatol Clin, 16, pp.277~288 (1998)
- Khaitan BK., "Extensive alopecia areata treated with betamethasone oral mini-pulse therapy : an open uncontrolled study", Indian J Dermatol Venereol Leprol, 70, pp.350~353 (2004)
- Sharma VK., "Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata", J Dermatol, 26, pp.562~565 (1999)
- Deshpande D., "Extensive alopecia areata : not necessarily recalcitrant to therapy!", Int J Trichology, 3, pp.80~83 (2011)
- Friedli A., "Pulse methylprednisolone therapy for severe alopecia areata : an open prospective study of 45 patients", J Am Acad Dermatol, 39, pp.597~602 (1998)
- Kahan BD, "Cyclosporine", N Engl J Med, 321, pp.1725~1738 (1989)
- Taylor M., "Cyclosporin A prolongs human hair growth in vitro", J Invest Dermatol, 100, pp.237~239 (1993)
- Gupta AK., "Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis", Arch Dermatol, 126, pp.339~350 (1990)
- Gupta AK., "Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis", J Am Acad Dermatol, 22, pp.242~250 (1990)
- 박주희, "중증 원형탈모증에서 고용량 스테로이드 주기 요법과 Cyclosporine과 저용량 스테로이드 병합 요법의 비교 연구", 대한피부과학회지, 47(11), pp.1220~1226 (2009), 대한피부과학회
- Sharma VK, "Pulsed administration of corticosteroids in the treatment of alopecia areata", Int J Dermatol, 35, pp.133~136 (1996)
- Jang JW., "Oral minipulse therapy with betamethasone in the treatment of alopecia areata", Korean J Dermatol, 39, pp.775~781 (2001)
- Alkhalifah A., "Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis", J Am Acad Dermatol, 62, pp.177~188 (2010)
- Wasserman D., "Alopecia areata", Int J Dermatol, 46, pp.121~131 (2007)
- Kim BJ., "Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata", J Dermatolog Treat, 19, pp.216~220 (2008)
- Tosti A., "Alopecia areata : a long term follow-up study of 191 patients", J Am Acad Dermatol, 55, pp.438~441 (2006)
- Madani S., "Alopecia areata update", J Am Acad Dermatol, 42, pp.549~566 (2000)
- Lew BL., "Acute diffuse and total alopecia : A new subtype of alopecia areata with a favorable prognosis", J Am Acad Dermatol, 60, pp.85~93 (2009)